nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2D6—Hydroxyurea—head and neck cancer	0.175	0.349	CbGbCtD
Trimipramine—CYP2C9—Fluorouracil—head and neck cancer	0.0733	0.146	CbGbCtD
Trimipramine—ABCB1—Vinblastine—head and neck cancer	0.0659	0.131	CbGbCtD
Trimipramine—CYP2D6—Vinblastine—head and neck cancer	0.0621	0.123	CbGbCtD
Trimipramine—ABCB1—Docetaxel—head and neck cancer	0.0543	0.108	CbGbCtD
Trimipramine—CYP3A4—Vinblastine—head and neck cancer	0.0395	0.0785	CbGbCtD
Trimipramine—CYP3A4—Docetaxel—head and neck cancer	0.0326	0.0647	CbGbCtD
Trimipramine—Ileus paralytic—Vinblastine—head and neck cancer	0.0164	0.047	CcSEcCtD
Trimipramine—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.0122	0.035	CcSEcCtD
Trimipramine—HTR1D—trigeminal nerve—head and neck cancer	0.0105	0.15	CbGeAlD
Trimipramine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00961	0.0275	CcSEcCtD
Trimipramine—HTR3A—cranial nerve—head and neck cancer	0.00923	0.132	CbGeAlD
Trimipramine—Numbness—Vinblastine—head and neck cancer	0.00858	0.0245	CcSEcCtD
Trimipramine—Sensory loss—Vinblastine—head and neck cancer	0.00821	0.0235	CcSEcCtD
Trimipramine—HRH1—nose—head and neck cancer	0.00798	0.114	CbGeAlD
Trimipramine—HTR1D—cranial nerve—head and neck cancer	0.0075	0.107	CbGeAlD
Trimipramine—Tingling sensation—Fluorouracil—head and neck cancer	0.00581	0.0166	CcSEcCtD
Trimipramine—Numbness—Fluorouracil—head and neck cancer	0.00563	0.0161	CcSEcCtD
Trimipramine—Sensory loss—Fluorouracil—head and neck cancer	0.00539	0.0154	CcSEcCtD
Trimipramine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00527	0.0151	CcSEcCtD
Trimipramine—Disorientation—Hydroxyurea—head and neck cancer	0.00526	0.0151	CcSEcCtD
Trimipramine—HTR2A—trigeminal nerve—head and neck cancer	0.00523	0.0747	CbGeAlD
Trimipramine—Throat sore—Docetaxel—head and neck cancer	0.00467	0.0134	CcSEcCtD
Trimipramine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00463	0.0133	CcSEcCtD
Trimipramine—Pancytopenia—Vinblastine—head and neck cancer	0.00424	0.0121	CcSEcCtD
Trimipramine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00392	0.0112	CcSEcCtD
Trimipramine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0039	0.0112	CcSEcCtD
Trimipramine—Myocardial infarction—Vinblastine—head and neck cancer	0.0039	0.0112	CcSEcCtD
Trimipramine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00386	0.0111	CcSEcCtD
Trimipramine—Disorientation—Fluorouracil—head and neck cancer	0.00379	0.0108	CcSEcCtD
Trimipramine—HTR2A—cranial nerve—head and neck cancer	0.00372	0.0532	CbGeAlD
Trimipramine—Agranulocytosis—Vinblastine—head and neck cancer	0.00371	0.0106	CcSEcCtD
Trimipramine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00371	0.0106	CcSEcCtD
Trimipramine—Weight increased—Hydroxyurea—head and neck cancer	0.0037	0.0106	CcSEcCtD
Trimipramine—Drowsiness—Hydroxyurea—head and neck cancer	0.00363	0.0104	CcSEcCtD
Trimipramine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00356	0.0102	CcSEcCtD
Trimipramine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00355	0.0102	CcSEcCtD
Trimipramine—Stomatitis—Hydroxyurea—head and neck cancer	0.00354	0.0101	CcSEcCtD
Trimipramine—Hallucination—Hydroxyurea—head and neck cancer	0.00324	0.00927	CcSEcCtD
Trimipramine—Ataxia—Fluorouracil—head and neck cancer	0.00319	0.00912	CcSEcCtD
Trimipramine—Alopecia—Vinblastine—head and neck cancer	0.00316	0.00903	CcSEcCtD
Trimipramine—Eosinophilia—Fluorouracil—head and neck cancer	0.0029	0.0083	CcSEcCtD
Trimipramine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00288	0.00825	CcSEcCtD
Trimipramine—Alopecia—Hydroxyurea—head and neck cancer	0.00288	0.00823	CcSEcCtD
Trimipramine—Malaise—Vinblastine—head and neck cancer	0.0028	0.00802	CcSEcCtD
Trimipramine—Pancytopenia—Fluorouracil—head and neck cancer	0.00278	0.00796	CcSEcCtD
Trimipramine—Convulsion—Vinblastine—head and neck cancer	0.00269	0.00771	CcSEcCtD
Trimipramine—Hypertension—Vinblastine—head and neck cancer	0.00268	0.00768	CcSEcCtD
Trimipramine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00263	0.00753	CcSEcCtD
Trimipramine—Discomfort—Vinblastine—head and neck cancer	0.00262	0.00748	CcSEcCtD
Trimipramine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00257	0.00737	CcSEcCtD
Trimipramine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00256	0.00732	CcSEcCtD
Trimipramine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00256	0.00732	CcSEcCtD
Trimipramine—Malaise—Hydroxyurea—head and neck cancer	0.00256	0.00732	CcSEcCtD
Trimipramine—Stomatitis—Fluorouracil—head and neck cancer	0.00255	0.00728	CcSEcCtD
Trimipramine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00248	0.00711	CcSEcCtD
Trimipramine—Convulsion—Hydroxyurea—head and neck cancer	0.00246	0.00703	CcSEcCtD
Trimipramine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00244	0.00697	CcSEcCtD
Trimipramine—Anorexia—Vinblastine—head and neck cancer	0.00242	0.00692	CcSEcCtD
Trimipramine—Discomfort—Hydroxyurea—head and neck cancer	0.00238	0.00682	CcSEcCtD
Trimipramine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00233	0.00667	CcSEcCtD
Trimipramine—Oedema—Hydroxyurea—head and neck cancer	0.00231	0.00662	CcSEcCtD
Trimipramine—Ataxia—Docetaxel—head and neck cancer	0.0023	0.00658	CcSEcCtD
Trimipramine—Paraesthesia—Vinblastine—head and neck cancer	0.00228	0.00652	CcSEcCtD
Trimipramine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00227	0.00648	CcSEcCtD
Trimipramine—Anorexia—Hydroxyurea—head and neck cancer	0.00221	0.00631	CcSEcCtD
Trimipramine—Decreased appetite—Vinblastine—head and neck cancer	0.00221	0.00631	CcSEcCtD
Trimipramine—Constipation—Vinblastine—head and neck cancer	0.00217	0.00621	CcSEcCtD
Trimipramine—Arrhythmia—Fluorouracil—head and neck cancer	0.00209	0.00599	CcSEcCtD
Trimipramine—Feeling abnormal—Vinblastine—head and neck cancer	0.00209	0.00598	CcSEcCtD
Trimipramine—Alopecia—Fluorouracil—head and neck cancer	0.00207	0.00593	CcSEcCtD
Trimipramine—Somnolence—Hydroxyurea—head and neck cancer	0.00206	0.00589	CcSEcCtD
Trimipramine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00204	0.00583	CcSEcCtD
Trimipramine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00201	0.00575	CcSEcCtD
Trimipramine—Pancytopenia—Docetaxel—head and neck cancer	0.00201	0.00574	CcSEcCtD
Trimipramine—Abdominal pain—Vinblastine—head and neck cancer	0.00201	0.00574	CcSEcCtD
Trimipramine—Fatigue—Hydroxyurea—head and neck cancer	0.002	0.00571	CcSEcCtD
Trimipramine—Constipation—Hydroxyurea—head and neck cancer	0.00198	0.00566	CcSEcCtD
Trimipramine—Weight increased—Docetaxel—head and neck cancer	0.00192	0.0055	CcSEcCtD
Trimipramine—Vision blurred—Fluorouracil—head and neck cancer	0.00192	0.0055	CcSEcCtD
Trimipramine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00191	0.00546	CcSEcCtD
Trimipramine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00186	0.00532	CcSEcCtD
Trimipramine—Myocardial infarction—Docetaxel—head and neck cancer	0.00185	0.00529	CcSEcCtD
Trimipramine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00185	0.00529	CcSEcCtD
Trimipramine—Stomatitis—Docetaxel—head and neck cancer	0.00184	0.00526	CcSEcCtD
Trimipramine—Jaundice—Docetaxel—head and neck cancer	0.00184	0.00526	CcSEcCtD
Trimipramine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00183	0.00523	CcSEcCtD
Trimipramine—Asthenia—Vinblastine—head and neck cancer	0.00182	0.00521	CcSEcCtD
Trimipramine—Convulsion—Fluorouracil—head and neck cancer	0.00177	0.00506	CcSEcCtD
Trimipramine—Agranulocytosis—Docetaxel—head and neck cancer	0.00176	0.00503	CcSEcCtD
Trimipramine—Diarrhoea—Vinblastine—head and neck cancer	0.00174	0.00497	CcSEcCtD
Trimipramine—Discomfort—Fluorouracil—head and neck cancer	0.00172	0.00491	CcSEcCtD
Trimipramine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00168	0.00482	CcSEcCtD
Trimipramine—Confusional state—Fluorouracil—head and neck cancer	0.00168	0.0048	CcSEcCtD
Trimipramine—Dizziness—Vinblastine—head and neck cancer	0.00168	0.0048	CcSEcCtD
Trimipramine—Oedema—Fluorouracil—head and neck cancer	0.00167	0.00477	CcSEcCtD
Trimipramine—Asthenia—Hydroxyurea—head and neck cancer	0.00166	0.00475	CcSEcCtD
Trimipramine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00163	0.00467	CcSEcCtD
Trimipramine—Tachycardia—Fluorouracil—head and neck cancer	0.00163	0.00465	CcSEcCtD
Trimipramine—Vomiting—Vinblastine—head and neck cancer	0.00161	0.00462	CcSEcCtD
Trimipramine—Headache—Vinblastine—head and neck cancer	0.00159	0.00455	CcSEcCtD
Trimipramine—Anorexia—Fluorouracil—head and neck cancer	0.00159	0.00454	CcSEcCtD
Trimipramine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00158	0.00453	CcSEcCtD
Trimipramine—Flushing—Docetaxel—head and neck cancer	0.00157	0.00449	CcSEcCtD
Trimipramine—Hypotension—Fluorouracil—head and neck cancer	0.00156	0.00445	CcSEcCtD
Trimipramine—HTR1D—connective tissue—head and neck cancer	0.00155	0.0221	CbGeAlD
Trimipramine—Dizziness—Hydroxyurea—head and neck cancer	0.00153	0.00438	CcSEcCtD
Trimipramine—Arrhythmia—Docetaxel—head and neck cancer	0.00151	0.00432	CcSEcCtD
Trimipramine—Nausea—Vinblastine—head and neck cancer	0.00151	0.00431	CcSEcCtD
Trimipramine—Insomnia—Fluorouracil—head and neck cancer	0.00151	0.00431	CcSEcCtD
Trimipramine—Paraesthesia—Fluorouracil—head and neck cancer	0.0015	0.00428	CcSEcCtD
Trimipramine—Alopecia—Docetaxel—head and neck cancer	0.0015	0.00428	CcSEcCtD
Trimipramine—Somnolence—Fluorouracil—head and neck cancer	0.00148	0.00424	CcSEcCtD
Trimipramine—Vomiting—Hydroxyurea—head and neck cancer	0.00147	0.00421	CcSEcCtD
Trimipramine—Dyspepsia—Fluorouracil—head and neck cancer	0.00147	0.00419	CcSEcCtD
Trimipramine—Rash—Hydroxyurea—head and neck cancer	0.00146	0.00417	CcSEcCtD
Trimipramine—Dermatitis—Hydroxyurea—head and neck cancer	0.00146	0.00417	CcSEcCtD
Trimipramine—Headache—Hydroxyurea—head and neck cancer	0.00145	0.00415	CcSEcCtD
Trimipramine—Decreased appetite—Fluorouracil—head and neck cancer	0.00145	0.00414	CcSEcCtD
Trimipramine—Dysgeusia—Docetaxel—head and neck cancer	0.00144	0.00413	CcSEcCtD
Trimipramine—Nausea—Hydroxyurea—head and neck cancer	0.00137	0.00393	CcSEcCtD
Trimipramine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00137	0.00393	CcSEcCtD
Trimipramine—Urticaria—Fluorouracil—head and neck cancer	0.00132	0.00379	CcSEcCtD
Trimipramine—Body temperature increased—Fluorouracil—head and neck cancer	0.00132	0.00377	CcSEcCtD
Trimipramine—Palpitations—Docetaxel—head and neck cancer	0.0013	0.00372	CcSEcCtD
Trimipramine—Convulsion—Docetaxel—head and neck cancer	0.00128	0.00365	CcSEcCtD
Trimipramine—Hypertension—Docetaxel—head and neck cancer	0.00127	0.00364	CcSEcCtD
Trimipramine—ADRA1B—head—head and neck cancer	0.00125	0.0178	CbGeAlD
Trimipramine—Dry mouth—Docetaxel—head and neck cancer	0.00123	0.00351	CcSEcCtD
Trimipramine—Confusional state—Docetaxel—head and neck cancer	0.00121	0.00347	CcSEcCtD
Trimipramine—Oedema—Docetaxel—head and neck cancer	0.0012	0.00344	CcSEcCtD
Trimipramine—Pruritus—Fluorouracil—head and neck cancer	0.00118	0.00337	CcSEcCtD
Trimipramine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00118	0.00337	CcSEcCtD
Trimipramine—Tachycardia—Docetaxel—head and neck cancer	0.00117	0.00336	CcSEcCtD
Trimipramine—Anorexia—Docetaxel—head and neck cancer	0.00115	0.00328	CcSEcCtD
Trimipramine—Diarrhoea—Fluorouracil—head and neck cancer	0.00114	0.00326	CcSEcCtD
Trimipramine—ADRA1A—epithelium—head and neck cancer	0.00113	0.0161	CbGeAlD
Trimipramine—Hypotension—Docetaxel—head and neck cancer	0.00112	0.00321	CcSEcCtD
Trimipramine—HTR3A—head—head and neck cancer	0.00112	0.016	CbGeAlD
Trimipramine—Dizziness—Fluorouracil—head and neck cancer	0.0011	0.00315	CcSEcCtD
Trimipramine—Insomnia—Docetaxel—head and neck cancer	0.00109	0.00311	CcSEcCtD
Trimipramine—Paraesthesia—Docetaxel—head and neck cancer	0.00108	0.00309	CcSEcCtD
Trimipramine—HTR2A—neck—head and neck cancer	0.00107	0.0153	CbGeAlD
Trimipramine—Somnolence—Docetaxel—head and neck cancer	0.00107	0.00306	CcSEcCtD
Trimipramine—Vomiting—Fluorouracil—head and neck cancer	0.00106	0.00303	CcSEcCtD
Trimipramine—Dyspepsia—Docetaxel—head and neck cancer	0.00106	0.00303	CcSEcCtD
Trimipramine—Rash—Fluorouracil—head and neck cancer	0.00105	0.003	CcSEcCtD
Trimipramine—Dermatitis—Fluorouracil—head and neck cancer	0.00105	0.003	CcSEcCtD
Trimipramine—Decreased appetite—Docetaxel—head and neck cancer	0.00105	0.00299	CcSEcCtD
Trimipramine—Headache—Fluorouracil—head and neck cancer	0.00104	0.00299	CcSEcCtD
Trimipramine—Fatigue—Docetaxel—head and neck cancer	0.00104	0.00297	CcSEcCtD
Trimipramine—Constipation—Docetaxel—head and neck cancer	0.00103	0.00294	CcSEcCtD
Trimipramine—Feeling abnormal—Docetaxel—head and neck cancer	0.000991	0.00283	CcSEcCtD
Trimipramine—Nausea—Fluorouracil—head and neck cancer	0.000989	0.00283	CcSEcCtD
Trimipramine—Body temperature increased—Docetaxel—head and neck cancer	0.00095	0.00272	CcSEcCtD
Trimipramine—Abdominal pain—Docetaxel—head and neck cancer	0.00095	0.00272	CcSEcCtD
Trimipramine—SLC6A3—head—head and neck cancer	0.000934	0.0133	CbGeAlD
Trimipramine—HRH1—connective tissue—head and neck cancer	0.00092	0.0132	CbGeAlD
Trimipramine—HTR1D—head—head and neck cancer	0.000912	0.013	CbGeAlD
Trimipramine—ADRA2A—connective tissue—head and neck cancer	0.000904	0.0129	CbGeAlD
Trimipramine—HTR2C—head—head and neck cancer	0.000903	0.0129	CbGeAlD
Trimipramine—HRH1—epithelium—head and neck cancer	0.000874	0.0125	CbGeAlD
Trimipramine—ADRA1A—lymphoid tissue—head and neck cancer	0.000869	0.0124	CbGeAlD
Trimipramine—Asthenia—Docetaxel—head and neck cancer	0.000863	0.00247	CcSEcCtD
Trimipramine—SLC6A4—head—head and neck cancer	0.000856	0.0122	CbGeAlD
Trimipramine—Pruritus—Docetaxel—head and neck cancer	0.000851	0.00243	CcSEcCtD
Trimipramine—Diarrhoea—Docetaxel—head and neck cancer	0.000823	0.00235	CcSEcCtD
Trimipramine—Dizziness—Docetaxel—head and neck cancer	0.000795	0.00227	CcSEcCtD
Trimipramine—HRH1—trachea—head and neck cancer	0.000773	0.011	CbGeAlD
Trimipramine—HTR2A—connective tissue—head and neck cancer	0.000769	0.011	CbGeAlD
Trimipramine—Vomiting—Docetaxel—head and neck cancer	0.000764	0.00219	CcSEcCtD
Trimipramine—HTR1A—head—head and neck cancer	0.00076	0.0109	CbGeAlD
Trimipramine—ADRA2A—trachea—head and neck cancer	0.000759	0.0108	CbGeAlD
Trimipramine—Rash—Docetaxel—head and neck cancer	0.000758	0.00217	CcSEcCtD
Trimipramine—Dermatitis—Docetaxel—head and neck cancer	0.000757	0.00217	CcSEcCtD
Trimipramine—SLC6A2—head—head and neck cancer	0.000753	0.0108	CbGeAlD
Trimipramine—Headache—Docetaxel—head and neck cancer	0.000753	0.00215	CcSEcCtD
Trimipramine—HTR2A—epithelium—head and neck cancer	0.00073	0.0104	CbGeAlD
Trimipramine—Nausea—Docetaxel—head and neck cancer	0.000714	0.00204	CcSEcCtD
Trimipramine—ADRA1A—head—head and neck cancer	0.0007	0.01	CbGeAlD
Trimipramine—DRD2—head—head and neck cancer	0.000687	0.00981	CbGeAlD
Trimipramine—HTR2A—trachea—head and neck cancer	0.000645	0.00922	CbGeAlD
Trimipramine—ADRA2A—thyroid gland—head and neck cancer	0.0006	0.00858	CbGeAlD
Trimipramine—HRH1—head—head and neck cancer	0.000542	0.00775	CbGeAlD
Trimipramine—ADRA2A—head—head and neck cancer	0.000533	0.00761	CbGeAlD
Trimipramine—SLC6A2—lymph node—head and neck cancer	0.000528	0.00754	CbGeAlD
Trimipramine—ABCB1—epithelium—head and neck cancer	0.000478	0.00683	CbGeAlD
Trimipramine—HTR2A—head—head and neck cancer	0.000453	0.00647	CbGeAlD
Trimipramine—ABCB1—trachea—head and neck cancer	0.000423	0.00604	CbGeAlD
Trimipramine—CYP2D6—head—head and neck cancer	0.000413	0.0059	CbGeAlD
Trimipramine—HRH1—lymph node—head and neck cancer	0.00038	0.00543	CbGeAlD
Trimipramine—ADRA2A—lymph node—head and neck cancer	0.000373	0.00533	CbGeAlD
Trimipramine—ABCB1—lymphoid tissue—head and neck cancer	0.000368	0.00526	CbGeAlD
Trimipramine—ABCB1—thyroid gland—head and neck cancer	0.000334	0.00478	CbGeAlD
Trimipramine—ABCB1—head—head and neck cancer	0.000297	0.00424	CbGeAlD
Trimipramine—ABCB1—lymph node—head and neck cancer	0.000208	0.00297	CbGeAlD
Trimipramine—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	2.25e-05	0.000291	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	2.21e-05	0.000286	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—DPYD—head and neck cancer	2.21e-05	0.000286	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—AKT1—head and neck cancer	2.2e-05	0.000285	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	2.2e-05	0.000284	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—MAPK1—head and neck cancer	2.18e-05	0.000282	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—EGFR—head and neck cancer	2.18e-05	0.000282	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL2—head and neck cancer	2.18e-05	0.000282	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	2.16e-05	0.00028	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCND1—head and neck cancer	2.13e-05	0.000275	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	2.11e-05	0.000272	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	2.11e-05	0.000272	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	2.11e-05	0.000272	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—YAP1—head and neck cancer	2.1e-05	0.000271	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—TYMS—head and neck cancer	2.1e-05	0.000271	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	2.09e-05	0.000271	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	2.09e-05	0.000271	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.09e-05	0.00027	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.08e-05	0.000269	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	2.07e-05	0.000268	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000268	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PTEN—head and neck cancer	2.05e-05	0.000265	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—TYMS—head and neck cancer	2.05e-05	0.000264	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—AKT1—head and neck cancer	2.04e-05	0.000264	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	2.04e-05	0.000264	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	2.04e-05	0.000263	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTM1—head and neck cancer	2.02e-05	0.000261	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	2.01e-05	0.00026	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	2.01e-05	0.000259	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	2e-05	0.000259	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	2e-05	0.000259	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	2e-05	0.000259	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	2e-05	0.000258	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.98e-05	0.000256	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.96e-05	0.000254	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	1.94e-05	0.000251	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GPX1—head and neck cancer	1.94e-05	0.00025	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.93e-05	0.000249	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.92e-05	0.000248	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	1.92e-05	0.000248	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	1.91e-05	0.000247	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.91e-05	0.000247	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	1.91e-05	0.000246	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.91e-05	0.000246	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	1.89e-05	0.000245	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.89e-05	0.000244	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	1.87e-05	0.000242	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	1.86e-05	0.00024	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	1.85e-05	0.000239	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	1.85e-05	0.000239	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	1.85e-05	0.000239	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—STAT3—head and neck cancer	1.83e-05	0.000237	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.83e-05	0.000236	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.83e-05	0.000236	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	1.82e-05	0.000235	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	1.82e-05	0.000235	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	1.82e-05	0.000235	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	1.82e-05	0.000235	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	1.81e-05	0.000234	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GPX1—head and neck cancer	1.81e-05	0.000234	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.81e-05	0.000233	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.79e-05	0.000231	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	1.78e-05	0.00023	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	1.78e-05	0.00023	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.77e-05	0.000228	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	1.75e-05	0.000226	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	1.75e-05	0.000226	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	1.74e-05	0.000225	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	1.74e-05	0.000225	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.74e-05	0.000225	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.73e-05	0.000224	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	1.7e-05	0.00022	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.7e-05	0.00022	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	1.69e-05	0.000218	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL2—head and neck cancer	1.68e-05	0.000218	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	1.68e-05	0.000217	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	1.67e-05	0.000215	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EGFR—head and neck cancer	1.67e-05	0.000215	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	1.66e-05	0.000214	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	1.65e-05	0.000214	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTGS2—head and neck cancer	1.65e-05	0.000213	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	1.64e-05	0.000212	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	1.64e-05	0.000212	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	1.64e-05	0.000211	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL2—head and neck cancer	1.63e-05	0.00021	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL2—head and neck cancer	1.62e-05	0.000209	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.61e-05	0.000209	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	1.61e-05	0.000208	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	1.6e-05	0.000207	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	1.59e-05	0.000205	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	1.59e-05	0.000205	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.58e-05	0.000204	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.58e-05	0.000204	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.58e-05	0.000204	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	1.58e-05	0.000204	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	1.57e-05	0.000202	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	1.55e-05	0.0002	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	1.55e-05	0.0002	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.55e-05	0.0002	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	1.53e-05	0.000198	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.52e-05	0.000197	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	1.51e-05	0.000195	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	1.49e-05	0.000193	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.49e-05	0.000192	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.48e-05	0.000192	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.47e-05	0.00019	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.46e-05	0.000189	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.46e-05	0.000188	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	1.46e-05	0.000188	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	1.45e-05	0.000187	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.44e-05	0.000186	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—head and neck cancer	1.44e-05	0.000186	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.44e-05	0.000186	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	1.43e-05	0.000185	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	1.43e-05	0.000185	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—head and neck cancer	1.43e-05	0.000184	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	1.42e-05	0.000184	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.42e-05	0.000183	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	1.42e-05	0.000183	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.42e-05	0.000183	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.4e-05	0.000182	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—head and neck cancer	1.4e-05	0.000181	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—head and neck cancer	1.4e-05	0.000181	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.39e-05	0.00018	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	1.39e-05	0.00018	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.38e-05	0.000179	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	1.38e-05	0.000178	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.37e-05	0.000178	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.37e-05	0.000177	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.37e-05	0.000177	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.37e-05	0.000177	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.36e-05	0.000176	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	1.35e-05	0.000175	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.34e-05	0.000174	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	1.34e-05	0.000173	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—head and neck cancer	1.34e-05	0.000173	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.33e-05	0.000172	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.32e-05	0.000171	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.32e-05	0.00017	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	1.32e-05	0.00017	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.31e-05	0.000169	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.31e-05	0.000169	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	1.3e-05	0.000168	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.3e-05	0.000168	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.29e-05	0.000167	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.29e-05	0.000167	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.29e-05	0.000167	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	1.29e-05	0.000166	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	1.29e-05	0.000166	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.29e-05	0.000166	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.28e-05	0.000165	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.26e-05	0.000163	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.26e-05	0.000163	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.25e-05	0.000161	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.25e-05	0.000161	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.25e-05	0.000161	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.24e-05	0.000161	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.24e-05	0.000161	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.24e-05	0.00016	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.24e-05	0.00016	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.21e-05	0.000157	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.2e-05	0.000155	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.2e-05	0.000155	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	0.000154	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.19e-05	0.000154	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	0.000154	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.18e-05	0.000153	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.18e-05	0.000153	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—head and neck cancer	1.18e-05	0.000153	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	0.000153	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.18e-05	0.000153	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	0.000152	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	0.000152	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.17e-05	0.000151	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.17e-05	0.000151	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	1.16e-05	0.00015	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.15e-05	0.000148	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.14e-05	0.000147	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.13e-05	0.000146	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.13e-05	0.000146	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	1.12e-05	0.000144	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.11e-05	0.000143	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.09e-05	0.000141	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.09e-05	0.000141	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	0.00014	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—head and neck cancer	1.08e-05	0.00014	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	1.08e-05	0.000139	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	0.000139	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	0.000139	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.07e-05	0.000139	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	0.000139	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.07e-05	0.000139	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	0.000139	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	0.000139	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.07e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.05e-05	0.000136	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.05e-05	0.000136	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—head and neck cancer	1.04e-05	0.000135	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.04e-05	0.000134	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	1.03e-05	0.000134	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.03e-05	0.000133	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	0.000133	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.02e-05	0.000132	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.01e-05	0.000131	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	9.99e-06	0.000129	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—head and neck cancer	9.95e-06	0.000128	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	9.94e-06	0.000128	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	9.94e-06	0.000128	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	9.78e-06	0.000126	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	9.77e-06	0.000126	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	9.51e-06	0.000123	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	9.48e-06	0.000122	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—head and neck cancer	9.37e-06	0.000121	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	9.33e-06	0.00012	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	9.31e-06	0.00012	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—head and neck cancer	9.29e-06	0.00012	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—head and neck cancer	9.17e-06	0.000118	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	9.13e-06	0.000118	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	9.13e-06	0.000118	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—head and neck cancer	9.02e-06	0.000117	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—head and neck cancer	9e-06	0.000116	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	8.83e-06	0.000114	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	8.82e-06	0.000114	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	8.77e-06	0.000113	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—head and neck cancer	8.77e-06	0.000113	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	8.63e-06	0.000111	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—head and neck cancer	8.61e-06	0.000111	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	8.48e-06	0.00011	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	8.45e-06	0.000109	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	8.4e-06	0.000109	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—head and neck cancer	8.29e-06	0.000107	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	8.21e-06	0.000106	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	7.85e-06	0.000101	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—head and neck cancer	7.74e-06	0.0001	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	7.62e-06	9.84e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—head and neck cancer	7.6e-06	9.82e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	7.46e-06	9.64e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	7.19e-06	9.29e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.03e-06	9.08e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—head and neck cancer	7.02e-06	9.07e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	6.93e-06	8.95e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.61e-06	8.54e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	6.55e-06	8.47e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—head and neck cancer	6.13e-06	7.92e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—head and neck cancer	5.87e-06	7.59e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—head and neck cancer	5.73e-06	7.41e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—head and neck cancer	5.4e-06	6.98e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—head and neck cancer	5.35e-06	6.92e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.32e-06	5.59e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.53e-06	4.56e-05	CbGpPWpGaD
